APA (7th ed.) Citation

H, W., E, S. M. N., P, A., R, K., D, O. S., I, G., . . . JR, S. (2025). Modified titration of donanemab reduces ARIA risk and maintains amyloid reduction. Alzheimer's & dementia : the journal of the Alzheimer's Association, 21(4), e70062. https://doi.org/10.1002/alz.70062

Chicago Style (17th ed.) Citation

H, Wang, et al. "Modified Titration of Donanemab Reduces ARIA Risk and Maintains Amyloid Reduction." Alzheimer's & Dementia : The Journal of the Alzheimer's Association 21, no. 4 (2025): e70062. https://doi.org/10.1002/alz.70062.

MLA (9th ed.) Citation

H, Wang, et al. "Modified Titration of Donanemab Reduces ARIA Risk and Maintains Amyloid Reduction." Alzheimer's & Dementia : The Journal of the Alzheimer's Association, vol. 21, no. 4, 2025, p. e70062, https://doi.org/10.1002/alz.70062.